Previous 10 | Next 10 |
2024-06-18 03:42:39 ET Summary Moderna's RSV vaccine has been approved by the FDA, but it faces competition from GSK and PFE's offerings. A June 26 meeting of the Advisory Committee on Immunization Practices is a near-term catalyst. MRNA is hoping for parity with GSK/PFE when it c...
2024-06-17 11:30:03 ET Summary Amgen continues to delight investors with the growth in sales of its key blockbusters and the expansion of its portfolio of medications. In mid-June, Amgen pleased investors by announcing that the FDA had approved Blincyto to treat certain patients w...
2024-06-16 08:12:27 ET Summary In recent months, Incyte's management has continued to delight investors by accelerating the pace of development of its anti-inflammatory treatments. On May 30, 2024, Incyte announced the completion of its acquisition of Escient Pharmaceuticals for $...
2024-06-14 10:59:33 ET More on bird flu CSL Seqirus to provide more than 40M bird flu vaccine doses to Europe Virax surges amid bird flu concerns Bird flu death in Mexico linked to strain not seen in humans before Third human bird flu case found...
2024-06-13 02:30:42 ET Summary A difficult period for Pfizer might be coming to an end, as serious setbacks and tough Y/Y comps are in the rearview mirror. The first quarter performance of the commercial business exceeded Street expectations, and the company maintained its full-ye...
2024-06-11 07:23:55 ET More on GSK GSK plc: Long-Term Cash Cow GSK Breathes New Life Into Asthma Treatment With Depemokimab GSK plc (GSK) Q1 2024 Earnings Call Transcript GSK, SpringWorks end collaboration agreement GSK wins FDA nod to expand label fo...
2024-06-10 14:58:39 ET More on CSL, bird flu Bird flu death in Mexico linked to strain not seen in humans before Travere, CSL win conditional nod for kidney disease therapy in EU Seeking Alpha’s Quant Rating on CSL Historical earnings data for CSL ...
2024-06-08 08:28:05 ET More on GSK, SpringWorks, etc. GSK plc: Long-Term Cash Cow GSK Breathes New Life Into Asthma Treatment With Depemokimab SpringWorks Therapeutics, Inc. (SWTX) Q1 2024 Earnings Call Transcript GSK wins FDA nod to expand label for RSV vacc...
2024-06-08 07:45:22 ET More on GSK, Agenus, etc. Agenus: Multiple Milestones In The Second Half Of 2024 GSK plc: Long-Term Cash Cow GSK Breathes New Life Into Asthma Treatment With Depemokimab GSK buys RNA therapeutics company for up to $50M Bird...
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes 1 Clinical development program continues to evaluate safety and immunogenicity in adults 18+ with data read-outs expected H2 2024 GSK plc (LSE/NYSE: GSK) today an...
News, Short Squeeze, Breakout and More Instantly...
2024-07-17 08:00:00 ET GSK (NYSE: GSK) , a global healthcare powerhouse, has been on a transformative journey since CEO Emma Walmsley took the helm in 2017. Despite its shares badly underperforming the S&P 500 under her first few years as CEO (see graph below), Walmsley's am...
2024-07-11 23:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
GSK supports annual flu immunization by getting FLULAVAL and FLUARIX to patients in advance of flu season GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its trivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2024-25 fl...